SCHEMBL18947633

SCHEMBL18947633

CCCN(C)S(=O)(=O)c1cccc(C(=O)Nc2ccc(F)c(C(F)F)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ TSHR P16473 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ NPSR1 Q6W5P4 2/20 0.52
▸ GAA P10253 1/20 0.52
▸ HTR2B P41595 1/20 0.51
▸ LMNA P02545 5/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ NPC1 O15118 2/20 0.48
▸ POLB P06746 2/20 0.47
▸ SIRT2 Q8IXJ6 5/20 0.47
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076755 0.92 HTR2B (0.51) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL15276897 0.80 HTR2B (0.53) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL23677205 0.80 HTR2B (0.57) HTR2BMEN1KMT2ACA12CA1
SCHEMBL15276896 0.79 LMNA (0.55) MAPTALDH1A1TSHRHTR2BLMNA
SCHEMBL15276935 0.79 ALDH1A1 (0.50) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL15612991 0.78 HTR2B (0.81) MAPTALDH1A1GAAHTR2BLMNA
SCHEMBL15076746 0.78 MEN1 (0.51) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL15276919 0.77 MAPT (0.53) MAPTALDH1A1HTR2BLMNASMN1; SMN2
SCHEMBL15280078 0.77 LMNA (0.48) MAPTALDH1A1TSHRMAPK1NPSR1
SCHEMBL15276895 0.77 LMNA (0.53) MAPTALDH1A1TSHRMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-A1 HEPATITIS B ANTIVIRAL AGENTS Novira Therapeutics Inc. (US) 2018-04-25 — — EP disclosed
US-9676747-B2 Hepatitis B antiviral agents NOVIRA THERAPEUTICS, INC. (US) 2017-06-13 — — US disclosed
Send feedback